CO-PRESENTING PARTNER
LIVE COVERAGE AND VIDEO PARTNERS
PARTNERS
CO-PRESENTING PARTNER
LIVE COVERAGE AND VIDEO PARTNERS
PARTNERS
Drug maker Alkem Laboratories on Monday said it has launched an antibiotic drug to treat multiple drug resistance infections.
The company's product Zidavi is a novel combination of ceftazidime & avibactam and is indicated for various ailments like complicated urinary tract infections.
With the rise in infections caused by carbapenem-resistant Gram-negative organisms in India, there is a need for more effective antibiotic treatment.
The available evidence suggests that Zidavi (ceftazidime-avibactam) is a potential therapeutic option for the treatment of infections complicated by multi-drug resistant (MDR) organisms, Alkem Laboratories said in a statement.
